Severe Type 2 Diabetes Induces Reversible Modifications of Endothelial Progenitor Cells Which are Ameliorate by Glycemic Control
暂无分享,去创建一个
C. Napoli | G. Paolisso | M. Barbieri | L. Sommese | N. Ferrara | C. Schiano | Vincenzo Grimaldi | M. D. De Pascale | A. Picascia | E. Crimi | A. Liguori | S. Brongo | G. Bruzzese
[1] K. Boström,et al. C‐peptide concentration, mortality and vascular complications in people with Type 2 diabetes. The Skaraborg Diabetes Register , 2015, Diabetic medicine : a journal of the British Diabetic Association.
[2] J. Lekakis,et al. Effect of aliskiren on circulating endothelial progenitor cells and vascular function in patients with type 2 diabetes and essential hypertension. , 2015, American journal of hypertension.
[3] Hong Wang,et al. Hyperhomocysteinemia and Hyperglycemia Induce and Potentiate Endothelial Dysfunction via μ-Calpain Activation , 2014, Diabetes.
[4] R. Fernandes,et al. Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum , 2014, Cardiovascular Diabetology.
[5] F. Gherlinzoni,et al. Prognostic Significance of Circulating and Endothelial Progenitor Cell Markers in Type 2 Diabetic Foot , 2014, International journal of vascular medicine.
[6] M. Małecki,et al. Number of circulating pro‐angiogenic cells, growth factor and anti‐oxidative gene profiles might be altered in type 2 diabetes with and without diabetic foot syndrome , 2013, Journal of diabetes investigation.
[7] Kai-HangYiu,et al. Specific Role of Impaired Glucose Metabolism and Diabetes Mellitus in Endothelial Progenitor Cell Characteristics and Function , 2014 .
[8] J. McDermott,et al. Endothelial progenitor cells and cardiovascular disease. , 2014, Journal of stem cells.
[9] C. Napoli,et al. Endothelial progenitor cells and human diseases , 2014, Annals of Hematology.
[10] C. Napoli,et al. Potential benefits of cell therapy in coronary heart disease. , 2013, Journal of cardiology.
[11] C. Desouza. Does drug therapy reverse endothelial progenitor cell dysfunction in diabetes? , 2013, Journal of diabetes and its complications.
[12] Ian A. White,et al. Impaired Endothelial Progenitor Cell Mobilization and Dysfunctional Bone Marrow Stroma in Diabetes Mellitus , 2013, PloS one.
[13] Hong Li,et al. Hyperglycaemia exerts deleterious effects on late endothelial progenitor cell secretion actions , 2013, Diabetes & vascular disease research.
[14] A. Józkowicz,et al. [Type 2 diabetes mellitus impairs endothelial progenitor cells functions]. , 2013, Postepy biochemii.
[15] G. Fadini. A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications , 2013, Diabetologia.
[16] W. Marston,et al. A Randomized, Controlled Pilot Study of Autologous CD34+ Cell Therapy for Critical Limb Ischemia , 2012, Circulation. Cardiovascular interventions.
[17] C. Napoli,et al. Glycoxydation promotes vascular damage Via MAPK‐ERK/JNK pathways , 2012, Journal of cellular physiology.
[18] Hiroshi Yamamoto,et al. Diabetes alters subsets of endothelial progenitor cells that reside in blood, bone marrow, and spleen. , 2012, American Journal of Physiology - Cell Physiology.
[19] H. Sritanaudomchai,et al. In vitro vessel-forming capacity of endothelial progenitor cells in high glucose conditions , 2012, Annals of Hematology.
[20] C. Siu,et al. Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus , 2011, Cardiovascular diabetology.
[21] C. Napoli,et al. Endothelial progenitor cells as therapeutic agents in the microcirculation: an update. , 2011, Atherosclerosis.
[22] S. Issaragrisil,et al. Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control , 2010, BMC endocrine disorders.
[23] R. Cubbon,et al. Effects of insulin resistance on endothelial progenitor cells and vascular repair. , 2009, Clinical science.
[24] C. Napoli,et al. Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease , 2008, European journal of haematology.
[25] C. Napoli,et al. Comparison between total endothelial progenitor cell isolation versus enriched Cd133+ culture. , 2007, Journal of biochemistry.
[26] M. Tendera,et al. Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism? , 2007, Heart.
[27] D. Link,et al. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. , 2006, Journal of the American College of Cardiology.
[28] Doris A Taylor,et al. Circulating endothelial progenitor cells predict coronary artery disease severity. , 2006, American heart journal.
[29] C. Heeschen,et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. , 2005, Journal of molecular and cellular cardiology.
[30] S. Fichtlscherer,et al. Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair , 2005, Circulation.
[31] J. Passauer,et al. PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. , 2005, Atherosclerosis.
[32] L. Tavazzi,et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. , 2005, Blood.
[33] R. Ferrari,et al. CD34+ and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure , 2004, Circulation.
[34] C. Napoli,et al. Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1. , 2001, European heart journal.
[35] J. Waltenberger. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. , 2001, Cardiovascular research.
[36] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.